Apoptosis of SK-HEP-1 human hepatoma cells induced by treatment with ginsenoside Rh2 (G-Rh2
tant role in protecting cells from apoptosis. Forced expression of p21 WAF1/CIP1 can block apoptosis during myocyte differentiation (4) . Moreover, in response to prostaglandin A2 or ionizing irradiation, p21
WAF1/CIP1(-/-) mutant cells and cells that downregulate the expression of p21 WAF1/CIP1 have been shown to be more susceptible to apoptosis than are wild cell types; this phenotype can be rescued by ectopic expression of p21 WAF1/CIP1 (5) .
Rapid up-regulation of Cdk activity has been shown to be associated with the onset of apoptosis in a number of experimental systems. These include growth factor-deprived human endothelial cells (6) , lymphocytes induced by granzyme B (7) or Fas (8) , and noncycling thymocytes induced by nonspecific (␥-irradiation, heat shock, or dexamethasone) or specific (peptidemediated) apoptotic stimuli (9) . Thus it has been suggested that Cdks, the key regulators of the cell division cycle, also play a pro-apoptotic role. This hypothesis is strongly supported by the observation that ectopic expression of a dominant negative version of Cdk2 (Cdk2-dn) partially suppresses apoptosis of human endothelial cells induced by growth factor deprivation (6) . In addition, olomoucine, which is a specific inhibitor of Cdks, efficiently suppresses apoptosis in noncycling thymocyte induced by various apoptotic stimuli (9) .
Although these studies provide evidence for a potentially essential role for Cdks in apoptosis, the mechanism of apoptotic activation of Cdks and their precise role in apoptosis have not been deciphered. Recently, we and others have shown that p21 WAF1/CIP1 undergoes caspase 3-mediated cleavage at a specific aspartate residue (Asp-112) during the early stage of apoptosis in various cell types induced by various stimuli (6, 10, 11) . Because p21 WAF1/CIP1 loses its nuclear localization sequence after cleavage by caspase 3, it has been suggested that caspase-mediated cleavage of Cdk inhibitors may contribute to the observed rapid up-regulation of Cdk activity in the early stage of apoptosis (6) .
Ginsenoside Rh2 (G-Rh2), a ginseng saponin with a dammarane skeleton that is isolated from the root of Panax ginseng C. A. Meyer, has been shown to inhibit cell growth and induce apoptosis in various cancer cell types (10, (12) (13) (14) . In the human hepatoma cell line SK-HEP-1, G-Rh2 present in the culture media at low concentrations (1 M) arrests the cell cycle at the G 1 /S transition by down-regulating cyclin E-Cdk2 kinase activity (12) . However, at higher concentrations (12 M), G-Rh2 induces apoptotic cell death through proteolytic activation of caspase 3. Apoptosis induced by treatment with G-Rh2 is not blocked by the ectopic expression of Bcl-2 in SK-HEP-1 cells, suggesting that G-Rh2 induces apoptosis by a mechanism that is not negatively regulated by the anti-apoptotic protein Bcl-2 (14) . Rather, in G-Rh2-induced apoptotic cells, p21
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aspartate 112 (context: DHVDL 113 ). The caspase 3 cleavage site is located between the N terminus and the nuclear translocation signal of p21 WAF1/CIP1 (10) . In the present study, we examined the role of caspase 3-mediated p21
WAF1/CIP1 cleavage in the induction of apoptosis in SK-HEP1 cells after treatment with G-Rh2. We demonstrate that the proteolytic cleavage of p21 WAF1/CIP1 , but not Cdk inhibitor p27
KIP1 , which also associates with cyclin-Cdk complexes, results in the selective and rapid activation of cyclin A-associated cyclin-dependent kinase 2 (cyclin A-Cdk2) kinase activity. Furthermore, we provide evidence that the truncation of p21
WAF1/CIP1 and consequent activation of cyclin A-Cdk2 are prerequisite events for the execution of apoptosis induced by treatment of cells with G-Rh2. Seoul National University Cancer Center and maintained as a monolayer culture in Dulbecco's modified Eagle's medium supplemented with 5% (by volume) heat-inactivated calf serum, 100 units/ml penicillin, and 100 g/ml streptomycin. Cells were cultured for 12 h in serumfree Dulbecco's modified Eagle's medium and then treated with G-Rh2 for the indicated time periods. Both floating and adherent cells were harvested for the immunoblotting experiments and histone H1 kinase assays. At the same time, another set of G-Rh2-treated cells were fixed, permeabilized in 4% paraformaldehyde, and then stained with DAPI solution to visualize nuclei and DNA. Fluorescent cells were photographed under the fluorescence microscope (Olympus).
EXPERIMENTAL PROCEDURES

Materials-G-Rh2
Human umbilical vein endothelial cells (HUVEC) were obtained from BioWhittaker, Inc., and cultured in endothelial cell growth medium kit 2 containing 2% fetal bovine serum (BioWhittaker, Inc.). Apoptosis was induced in 40% confluent cell monolayers by treatment with RPMI 1640 medium containing 12 M G-Rh2 or in confluent cell monolayers by incubating the cells in RPMI 1640 medium without growth factors.
cDNA Cloning, Expression Vector Construction, and Site-directed Mutagenesis Ϫ-Full-length human cyclin A cDNA generated by reverse transcription-polymerase chain reaction (using oligo 5Ј-AAG-GATCCAGCCTATTCTTTGGCC-3Ј and 5Ј-AAGGATCCGGCAGCTG-GCATCATTAATAC-3Ј) with BamHI sites at the 5Ј and 3Ј ends was cloned into the pCMV expression vector. Human Cdk2 and Cdk2-dn cDNAs were kindly provided by Dr. Ewen Mark (Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA). Human full-length p21 WAF1/CIP1 cDNA (2.1 kilobase pairs) was inserted into pCMV vector. Substitution of Asn-112 for Asp-112 was accomplished by converting the Asp codon GAC to AAC by site-directed mutagenesis (CLONTECH). The full-length cyclin A cDNA sequence and the presence of the G-to-A mutation of p21 WAF1/CIP1 were confirmed by DNA sequencing.
Transient Transfections and Analysis of Transfected Cells by X-Gal
Staining-SK-HEP-1 cells (2 ϫ 10 5 ) were co-transfected with either 2 g each of pCMV-p21 WAF1/CIP1 and pCMV-␤-galactosidase or pCMVp21D112N and pCMV-␤-galactosidase using 8 l of Superfect (Qiagen) as described by the manufacturer. Forty-eight hours after transfection, apoptosis was induced in the transfected cells with the addition of 12 M G-Rh2. When about 50% of the total cells revealed apoptotic morphology, cells were stained with X-gal and examined with phase-contrast microscopy as described (15) . To determine the extent of apoptosis, we counted blue cells that were rounded and exhibited blebbing on 17 randomly selected fields (40 -50 cells per field) under a phase contrast microscope (Olympus) at a magnification of ϫ 150.
HeLa cells were also used for transient transfection studies because of their high transfection efficiency (Ͼ80%). HeLa cells (2.5 ϫ 10 5 ) grown on six-well plastic plates were transfected with 0.5-2 g of each expression vector per sample using 8 l of Superfect (Qiagen). Twentyfour hours after transfection, cells were trypsinized, counted, and plated at 1.5 ϫ 10 3 cells/well into 96-well microtiter plates. After 24 h of incubation, cells were treated with G-Rh2 for 24 h, and then 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reagents were added to each microculture well. After 2 h of incubation, the precipitated formazan crystals were dissolved in DMSO and measured with an ELISA reader (Tecan).
Immunoblot Analysis-Cells were washed with ice-cold phosphatebuffered saline and solubilized in immunoprecipitation lysis buffer containing 20 mM Tris, pH 7.5, 0.5% Triton X-100, 2 mM MgCl 2 , 1 mM dithiothreitol, 1 mM EGTA, 50 mM ␤-glycerol phosphate, 25 mM NaF, 1 mM Na 3 VO 4 , 2 g/ml leupeptin, 2 g/ml pepstatin A, 2 g/ml antipain, and 1 mM phenylmethylsulfonyl fluoride. After incubation on ice for 1 h, the insoluble materials were removed by centrifugation at 12,000 g for 15 min. An aliquot (30 g of protein) from each sample was resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto a polyvinylidene difluoride membrane (Gelman). The membrane was blocked with 5% nonfat milk and probed with mouse monoclonal antibodies to p21 WAF1/CIP1 or p27 KIP1 (Upstate Biotechnology, Inc.), with cyclin A or cyclin E (Santa Cruz Biotechnology), or with polyclonal rabbit antibodies (Santa Cruz Biotechnology) to Cdk2 (raised against the C-terminal peptide of Cdk2) and polyadenylribosyl polymerase (PARP). The blots were washed, incubated with a horseradish peroxidase-coupled anti-mouse IgG or anti-rabbit IgG (Pierce), and then visualized by ECL (Amersham Pharmacia Biotech).
Immunoprecipitation and Histone H1 Kinase Assay-An aliquot (500 g of protein) from each cell extracts was precleared with protein A-agarose beads (Upstate Biotechnology, Inc.), and the supernatant was incubated with polyclonal rabbit antibodies to cyclin A or cyclin E for 4 h. Immune complexes associated with cyclin A or cyclin E were collected after incubating for 2 h with protein A-agarose beads. The immune complexes were then resolved by SDS-PAGE and analyzed for their components by immunoblotting using corresponding mouse monoclonal antibodies.
Immune complexes obtained from aliquots (200 g of protein) of each cell extracts as described above were washed three times with immunoprecipitation lysis buffer and twice with kinase assay buffer containing 50 mM Tris, pH 7.5, 10 mM MgCl 2 , 1 mM dithiothreitol, 1 mM EGTA, 50 mM ␤-glycerol phosphate, 25 mM NaF, 0.1 mM Na 3 VO 4 , 1 g/ml leupeptin, 1 g/ml pepstatin A, 1 g/ml antipain, and 1 mM phenylmethylsulfonyl fluoride. The immune complexes were then incubated for 15 min at 30°C in 50 l of the kinase assay buffer supplemented with 5 g of histone H1 (Life Technologies, Inc.), 10 Ci of [␥-
32 P]ATP (10 M), 5 M PKI (protein kinase A inhibitor), and 20 mM EGTA, and the proteins were resolved by 12% SDS-PAGE. Cyclin-associated kinase activities were then determined by autoradiography.
RESULTS
Activation of cyclin A-Cdk2 during Apoptosis-It is known
that Cdk activity is up-regulated in the early stage of apoptosis of human hepatoma SK-HEP-1 cells induced by G-Rh2. To decipher the mechanism by which Cdk activity is induced in the process of apoptosis, we examined the Cdk activities in SK-HEP-1 cells after treatment with G-Rh2. After treatment of SK-HEP-1 cells with G-Rh2 (12 M) for 1 h, individual cells showed the typical morphological changes that occur during apoptosis, such as cell rounding and membrane blebbing (Fig.  1A) . DAPI staining of the cells showed that G-Rh2 treatment also induced chromatin condensation and nuclear fragmentation within a similar range of time after treatment (Fig. 1B) . Furthermore, immunoblotting analysis showed that proteolytic activation of procaspase 3 to yield catalytically active 17-kDa caspase 3 and PARP cleavage to yield the 85-kDa version of the protein occurred in SK-HEP-1 cells 1 h after treatment with G-Rh2 (Fig. 1C) .
We then immunoprecipitated the cyclin A-and cyclin E-dependent kinases from G-Rh2-treated SK-HEP-1 cell lysates and used histone H1 as a substrate to measure the amount of each specific Cdk activity. Cyclin A-Cdk2 activity was elevated 1-2-fold in cells that had been treated with G-Rh2 for 1 h compared to levels in control (vehicle-treated) cells (Fig. 1, D and E). Cyclin A-Cdk2 activity was elevated further by 2-3-fold after 2 h of treatment with G-Rh2 (Fig. 1, D and E) . These results show that cyclin A-dependent kinase activity is upregulated in the early stages of apoptosis and that this upregulation is progressive over time and occurs in parallel with the process of apoptosis. By contrast, cyclin E-dependent kinase 2 (cyclin E-Cdk2) activity remained unaltered under the same experimental conditions (Fig. 1, D 
and E). Proteolytic Cleavage of p21 WAF1/CIP1 Is Crucial for the Rapid Activation of Cyclin A-Cdk2 Activity in G-Rh2-induced Apoptotic SK-HEP-1 Cells-To test whether the up-regulation of cyclin A-Cdk2 activity in apoptotic cells is associated with the proteolytic cleavage of Cdk inhibitors p21
WAF1/CIP1 or p27 KIP1 , we measured the amounts of these inhibitory proteins in SK-HEP-1 cells before and after treatment with G-Rh2. Immunoblotting analyses showed that cleavage of p21 WAF1/CIP1 to yield p14 and p27 KIP1 to yield p23 was induced at 1 and 4 h, respectively, after treatment of cells with G-Rh2 (Fig. 2A) . Thus, the proteolytic truncation of p21 WAF1/CIP1 precedes that of p27
KIP1
by 3 h in the process of apoptosis of SK-HEP-1 cells induced by G-Rh2 treatment.
We then examined whether the truncated versions of these Cdk inhibitors were associated with cyclin-Cdk complexes. For these experiments, we carried out immunoblotting analyses of immune complexes that were immunoprecipitated from SK-HEP-1 cells with specific antibodies to cyclin A or cyclin E. These analyses showed that p21 WAF1/CIP1 that was associated with cyclin A-Cdk2 but not with cyclin E-Cdk2 underwent proteolytic cleavage after cells were treated for 1 h with G-Rh2. As expected, p21 WAF1/CIP1 that was associated with the cyclin E-Cdk2 complex remained unaltered under the same experimental conditions. In addition, the amount of p27
KIP1 that was associated with cyclin E-Cdk2 did not change with G-Rh2 treatment; however, the amount of p27
KIP1 that was associated with cyclin A-Cdk2 decreased slightly after cells were incubated with G-Rh2 for 4 h (Fig. 2, B and C) . Thus, the timing of proteolytic cleavage of p21 WAF1/CIP1 upon treatment of cells with G-Rh2 agrees very well with that of the rapid up-regulation of cyclin A-Cdk2 kinase activity in the apoptotic cells. This series of experiments also showed that the amounts of cyclin A, cyclin E, and Cdk2 in the kinase complexes did not change upon G-Rh2 treatment relative to control cells. Taken together, these results suggest that the rapid activation of cyclin A-Cdk2 kinase activity observed in the early stages of apoptosis is caused by the proteolytic cleavage of p21 WAF1/CIP1 that is associated with the cyclin A-Cdk2 complex.
p21D112N Down-regulates Apoptosis and Cyclin A-Cdk2 Kinase Activity More Efficiently Than Does p21
WAF1/CIP1 in Cells Treated with G-Rh2-Our next goal was to provide evidence for the notion that proteolytic cleavage of p21 WAF1/CIP1 is linked functionally to the up-regulation of cyclin A-Cdk2 kinase activity observed in apoptotic cells. To this end, we examined whether ectopic overexpression of p21D112N, a mutant version FIG. 1. Activation of cyclin A-associated kinase activity during G-Rh2-induced apoptosis. SK-HEP-1 cells were treated with 12 M G-Rh2 for the indicated times and photographed by phase contrast microscopy (ϫ 100) (A) or fluorescence microscopy (ϫ 100) after staining the cells with DAPI (B). C, cells were disrupted, and equal amounts of cell extracts were resolved by 12% SDS-PAGE and analyzed by immunoblotting using specific antibodies to caspase 3 and PARP. In C, procaspase 3, caspase 3 (17 kDa), PARP, and truncated PARP (85 kDa) are indicated by arrows. D, cyclin A-dependent and cyclin E-dependent kinases were immunoprecipitated from cell extracts using specific antibodies to cyclin A or cyclin E, and the corresponding kinase activities were determined using histone H1 as a substrate. For quantitation, the cyclin A-and cyclin E-associated kinase activities in D were densitometrically measured with a phosphorimager (Fuji). These results are expressed in histograms as kinase activities relative to those of control cells treated with vehicle (E).
FIG. 2. p21
WAF1/CIP1 associated with cyclin A-Cdk2, but not with cyclin E-Cdk2, undergoes proteolytic cleavage in the early stages of apoptosis. Cell extracts were prepared from SK-HEP-1 cells after treatment with G-Rh2 and resolved by SDS-PAGE as described in Fig. 1 . A, protein levels of p21 WAF1/CIP1 and p27 KIP1 in the cell extracts were analyzed by immunoblotting using specific antibodies to each corresponding protein.
Amounts of p21
WAF1/CIP1 and p27 KIP1 associated with cyclin A-Cdk2 (B) or cyclin E-Cdk2 (C) complexes were analyzed similarly by immunoblotting of the immunoprecipitated kinase complexes using polyclonal antibodies to human cyclin A or E.
of p21
WAF1/CIP1 that is resistant to caspase 3 cleavage, can suppress apoptosis more efficiently than does overexpression of wild type p21 WAF1/CIP1 in SK-HEP-1 cells treated with G-Rh2 (Fig. 3) . Because the transfection efficiency of SK-HEP-1 cells is relatively low (less than 30%), we differentiated between transfectants and untransfected cells using X-gal blue staining after co-transfection of the cells with a ␤-galactosidase expression vector and a vector that expressed either p21 WAF1/CIP1 or p21D112N. The blue-stained transfectants were then evaluated morphologically to determine the number of apoptotic cells (rounded shape and membrane blebbing) and viable cells (elongated in shape) (Fig. 3A) . G-Rh2 induced apoptosis in 53% of mock-transfected SK-HEP-1 cells, whereas the apoptosisinducing effect of G-Rh2 was reduced significantly to 26 and 11%, respectively, in p21 WAF1/CIP1 and p21D112N transfectants under identical experimental conditions (Fig. 3B) . These data suggest that proteolytic cleavage of p21 WAF1/CIP1 is important for the induction of apoptosis.
Because of the low transfection efficiency, we were unable to measure cyclin A-Cdk2 activity using SK-HEP-1 cells. Therefore, we investigated the effect of overexpression of p21 WAF1/CIP1 and p21D112N on cyclin A-Cdk2 activity and apoptosis using HeLa cells. HeLa cells were chosen for the following reasons. First, the transfection efficiency of HeLa cells is high enough (Ͼ80%) to perform biochemical assays. Second, our preliminary experiments showed that HeLa cells undergo apoptotic cell death in a manner similar to SK-HEP-1 cells after treatment with G-Rh2 (data not shown). As shown in Fig. 4A , the amounts of p21D112N and p21 WAF1/CIP1 increased in transfected cells in a dose-dependent manner with increasing amounts of transfected DNA. Using these transfectants, we examined cyclin A-Cdk2 kinase activity in the cells after treatment with G-Rh2. Both classes of transfectants showed significant down-regulation of cyclin A-Cdk2 kinase activity, which occurred in a dose-dependent manner with increasing amounts of transfected DNA (Fig. 4B ). In agreement with the results obtained with transfected SK-HEP-1 cells, viability of the p21D112N transfectants was significantly higher than that of the p21 WAF1/CIP1 transfectants (ϳ71% versus ϳ39%), and the changes in cell viability were dose-and time-dependent (Fig. 4,  C and D) .
We next compared the cyclin A-Cdk2 kinase activity in extracts of transfected cells after treatment of G-Rh2. As shown in Fig. 4E, p21D112N transfectants exhibited much lower cyclin A-Cdk2 kinase activity than did the p21 WAF1/CIP1 transfectants after treatment of HeLa cells with G-Rh2. As expected, kinase activity in the mock transfectants, which were transfected with the vector DNA, was much higher than that in p21D112N or p21 WAF1/CIP1 transfectants. Under the same experimental conditions used in Fig. 4E , we examined the levels of proteins that are associated with the cyclin A-Cdk2 kinase complex in transfected HeLa cells after treatment with G-Rh2. Immunoblotting analyses were carried out with immune complexes that were precipitated from extracts of G-Rh2-treated, transfected HeLa cells with specific antibodies to cyclin A. The levels of co-immunoprecipitated p21D112N from p21D112N-transfected cells were significantly higher than the levels of p21 WAF1/CIP1 co-immunoprecipitated from p21 WAF1/CIP1 -transfected cells (Fig. 4F) . In apoptotic mock transfectants, the levels of p21 WAF1/CIP1 were undetectable. Thus, it appears that proteolytic cleavage of p21 WAF1/CIP1 that is associated with cyclin A-Cdk2 plays an important role in the up-regulation of cyclin A-Cdk2 kinase activity and induction of apoptosis in both SK-HEP-1 and HeLa cells treated with G-Rh2. In addition, the 
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rapid up-regulation of cyclin A-Cdk2 kinase activity may be required in the process of apoptosis induced by G-Rh2 treatment.
Up-regulation of Cyclin A-Cdk2 Kinase Activity Is a Prerequisite for Apoptosis-Because overexpression of either p21D112N or p21
WAF1/CIP1 suppressed apoptosis as well as the increase in cyclin A-Cdk2 kinase activity in both SK-HEP-1 and HeLa treated with G-Rh2, we tested whether up-regulation of cyclin A-Cdk2 kinase activity is required for the progression of apoptosis. We first examined whether olomoucine, a specific cyclin-Cdk2 inhibitor, can block apoptosis of SK-HEP-1 induced by treatment with G-Rh2. Incubation of G-Rh2-treated SK-HEP-1 cells with olomoucine suppressed the development of morphological changes and chromatin fragmentation (Fig.  5A ). In addition, the viability levels of G-Rh2-treated cells were restored to the level of untreated cells in a dose-dependent manner (Fig. 5B) .
The results suggest that the apoptosis of cells induced by treatment with G-Rh2 requires the up-regulation of Cdk activity. To test whether up-regulation of cyclinA-Cdk2 kinase activity is required for the progression of apoptosis, we transiently transfected HeLa cells with expression vectors that encoded either cyclin A, Cdk2-dn, or both. Immunoblotting analysis showed that expression of the corresponding transfected DNAs increased in a dose-dependent manner (Fig. 6A ). Using these transient transfectants, we carried out immune complex cyclin A-Cdk2 kinase assays after treatment of the transfected cells with G-Rh2. In the cyclin A transfectants, cyclin A-Cdk2 kinase activity increased dramatically in a DNA dose-dependent manner compared with kinase activity in mock transfectants (Fig. 6B) . As expected, the increased cyclin ACdk2 kinase activity levels induced by overexpression of cyclin A were reduced to levels observed in mock transfectants by co-transfection of Cdk2-dn. In addition, cyclin A-Cdk2 kinase activity was shown to be decreased significantly in Cdk2-dn transfectants when compared with that of mock transfectants (Fig. 6B) . The viability of cyclin A transfectants was decreased dramatically (Fig. 6C ). However, cell viability was restored to the levels of mock transfectants by co-transfection of Cdk2-dn. Overexpression of Cdk2-dn alone yielded cell viability levels higher than those obtained for mock transfectants. In this experiment, we used a lower concentration of G-Rh2 (6 M) to adjust the cell viability of G-Rh2-induced mock transfectants to higher than about 70%, because this experiment was also aimed at testing whether forced expression of cyclin A accelerates apoptosis induced by treatment with G-Rh2.
We next examined changes over time in the levels of cyclin A-Cdk2 kinase activity in the above transfectants after treatment with G-Rh2. Cyclin A-Cdk2 kinase activity was up-regulated dramatically in a time-dependent manner in the cyclin A transfectants compared with that of the mock transfectants (Fig. 6D) . When cells were co-transfected with cyclin A and Cdk2-dn, this up-regulation of cyclin A-Cdk2 kinase activity was again efficiently suppressed to levels that were even lower than those of the mock transfectants after treatment with G-Rh2. Cyclin A-Cdk2 kinase activity in Cdk-dn transfectants was significantly lower than that of mock transfectants after treatment with G-Rh2. These results demonstrate that upregulation of cyclin A-Cdk2 kinase activity is required for the progression of apoptosis in G-Rh2-induced HeLa cells.
DISCUSSION
In this article, we have described four major observations: (i) ectopic overexpression of a mutant version of p21 WAF1/CIP1 , p21D112N, which is not susceptible to proteolysis by caspase 3, efficiently blocks G-Rh2-induced apoptosis in SK-HEP-1 cells; (ii) cyclin A-Cdk2 kinase activity but not cyclin E-Cdk2 activity is up-regulated in the early stages of apoptosis; (iii) up-regulation of cyclin A-Cdk2 kinase activity is a consequence of proteolytic cleavage of p21 WAF1/CIP1 that is associated with the cyclin A-Cdk2 complex; and (iv) proteolytic cleavage of p21 WAF1/CIP1 associated with the cyclin A-Cdk2 complex is a prerequisite process, not only for up-regulation of cyclin ACdk2 kinase activity in apoptotic cells but also for the initiation and progression of apoptosis.
Temporal Coordination of Cyclin A-Cdk2 Activation and the Initiation of Apoptosis-When apoptosis is induced in SK-HEP-1 cells by treatment with G-Rh2, we observed that proteolytic activation of caspase 3, up-regulation of cyclin A-Cdk2 kinase activity, and the initiation of apoptosis all occur within the same time period after G-Rh2 induction. An earlier report showed that both cyclin A-Cdk2 and cyclin E-Cdk2 activities are up-regulated under conditions where growth factor deprivation induces apoptosis in HUVEC (6) . In this study, we   FIG. 4 . The suppressive effect on apoptotic cell death of p21D112N is much greater than that of p21 WAF1/CIP1 wild type (p21 wt). HeLa cells were transiently transfected with the indicated amounts of an expression vector that harbored either the p21 wt or p21D112N coding region. A, 48 h after transfection, the amounts of p21 wt and p21D112N in the transfected cells were analyzed by immunoblotting using a specific antibody to p21
WAF1/CIP1
. B, cyclin A-Cdk2 kinase activities in the transfectants were determined as a function of the amount of DNA transfected. C, the transfected cells were treated with 12 M G-Rh2 for 24 h, and their percentage of viability was assayed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis as a function of the amount of DNA transfected in the cells. In the experiments shown in D-F, HeLa cells were transfected with 2 g/ml of the indicated DNAs and then treated for the indicated periods with 12 M G-Rh2. D, the percentage of viability over time of the transfectants was determined by the trypan blue exclusion method. Cyclin A-dependent kinase activities (E) and amounts of the proteins associated with the cyclin A-Cdk2 complex in the transfectants (F) were determined in a time-dependent manner as described in the legend to Fig. 2. observed that cyclin E-Cdk2 kinase activity remained unaltered until SK-HEP-1 cells had been treated with G-Rh2 for 4 h, and at that time, the apoptotic process was nearly completed. Thus, we ruled out the possibility that cyclin E-Cdk2 plays a role in the early stages of apoptosis in SK-HEP-1 cells induced by G-Rh2.
The selective up-regulation of cyclin A-Cdk2 kinase activity appears to be the result of proteolytic cleavage of p21
that is associated with the cyclin A-Cdk2 complex. We observed that a marked reduction in the amount of p21 WAF1/CIP1 that is associated with the cyclin A-Cdk2 complex coincided with the up-regulation of cyclin A-Cdk2 kinase activity. In contrast, the A, 48 h after transfection, the amounts of the indicated proteins in the transfectants were determined by immunoblotting using specific antibodies to cyclin A and Cdk2. B, cyclin A-dependent kinase activity in the transfectants was determined as a function of the amount of DNA transfected. C, transfected cells were treated with 6 M G-Rh2 for 24 h, and the percentage of cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis. D, HeLa cells were transfected with 2 g/ml of the indicated DNAs and treated for the indicated times with 12 M G-Rh2. Cyclin A-dependent kinase activity in the transfectants was determined as described under "Experimental Procedures."
amounts of p21
WAF1/CIP1 and p27 KIP1 that were associated with the cyclin E-Cdk2 complex remained unaltered. An earlier report showed that proteolysis of p21 WAF1/CIP1 and p27 KIP1 is involved in the up-regulation of both cyclin A-Cdk2 and cyclin E-Cdk2 kinase activities in apoptotic HUVEC induced by growth factor deprivation (6) . In this study, we also observed that p27 KIP1 undergoes proteolytic cleavage, but not until SK-HEP-1 cells have been treated with G-Rh2 for 4 h, when the apoptosis is nearly completed and cyclin A-Cdk2 kinase activity has been down-regulated. Furthermore, the amount of p27 KIP1 that is associated with both cyclin A-Cdk2 and cyclin E-Cdk2 complexes was unaltered during apoptosis in SK-HEP-1 cells. To determine whether these differences reflect differences in the cells studied or in the means by which apoptosis was induced, we extended this study to the induction of apoptosis in HUVEC by treatment with G-Rh2 or growth factor deprivation (Fig. 7) . The results showed that G-Rh2 equally induces proteolytic cleavage of PARP in HUVEC as does it in SK-HEP-1 cells. Cyclin A-Cdk2 activity markedly increased, whereas cyclin E-Cdk2 activity remained unchanged in HUVEC after treatment with G-Rh2. In addition, increases in cyclin A-Cdk2 activity in apoptotic HUVEC kinetically coincided well with increases in proteolytic cleavages of PARP and p21
WAF1/CIP1
but not with an increase in that of p27 KIP1 . By contrast, in apoptotic HUVEC induced by growth factor deprivation, we observed that p21 WAF1/CIP1 and p27 KIP1 undergo proteolytic cleavages with subsequent increases in both cyclins A-and E-dependent kinase activities as described previously (6) . The appearance of the p21 WAF1/CIP1 fragment preceded the appearance of the p27 KIP1 fragment by 2-4 h after growth factor deprivation. A marked increase in cyclin A-Cdk2 activity preceded an increase in cyclin E-Cdk2 activity by 4 h in apoptotic HUVEC. These results clearly suggest that G-Rh2-induced apoptosis occurs by a different mechanism than growth factor deprivation-induced apoptosis in HUVEC. Our results also indicate that apoptosis in HUVEC and SK-HEP-1 cells induced by G-Rh2 may proceed by a similar mechanism.
It is interesting to note that both cyclin A-Cdk2 and cyclin E-Cdk2 form complexes with p27 KIP1 and p21 WAF1/CIP1 before SK-HEP-1 cells commit to apoptosis after treatment with GRh2. This phenomenon suggests that both cyclin kinase inhibitors, p27
KIP1 and p21 WAF1/CIP1 , may play a protective role in guarding cells against apoptosis (see below). However, results described in this report suggest that p21
WAF1/CIP1 that is associated with the cyclin A-Cdk2 complex is more susceptible to caspase 3-like enzymes than is kinase-associated p27 KIP1 .
Therefore, p21 WAF1/CIP1 may play a distinct role in apoptosis, such as the selective up-regulation of cyclin A-Cdk2 kinase activity in the initial stages of apoptosis.
Proteolysis of p21 WAF1/CIP1 and Initiation of Apoptosis-Our result indicate that proteolytic cleavage of p21
WAF1/CIP1 at Asp-112 is a prerequisite event for the up-regulation of cyclin A-Cdk2 kinase activity in SK-HEP-1 cells induced to enter apoptosis by treatment with G-Rh2. We (10) and others (6, 11) have shown that caspase 3 specifically cleaves p21
WAF1/CIP1 at DHVDL 113 , which is located near the nuclear translocation signal. It has been suggested that cleavage of p21 WAF1/CIP1 by caspase 3 or a caspase 3-like protease at Asp-112 can prevent nuclear translocation of this Cdk inhibitor and hence may result in the up-regulation of cyclin-Cdk2 kinase activity in the nucleus (6) . In this study, we used a noncleavable p21
mutant, p21D112N, to show that ectopic overexpression of a noncleavable form of p21 WAF1/CIP1 inhibits the up-regulation of G-Rh2-induced cyclin A-Cdk2 kinase activity (Fig. 4E) .
Protective Role of p21 WAF1/CIP1 -Results herein and from other studies (4, 5) imply that p21 WAF1/CIP1 is a protective factor, guarding cells against apoptosis. A number of observations suggest that part of this protective function may be achieved by preventing Cdk2 activation. First, overexpression of p53 induces apoptosis only when p21 WAF1/CIP1 fails to increase proportionally, and conversely, overexpression of p21 WAF1/CIP1 blocks p53-induced apoptosis (16) . Second, mutated p21
WAF1/CIP1 lacking Cdk-inhibitory activity fails to prevent apoptosis in colorectal carcinoma cells (17) . Third, all nonspecific (␥-irradiation, heat shock, or dexamethasone) and specific (peptide-mediated) apoptotic stimuli induce rapid activation of the Cdk2 in noncycling thymocytes. In addition, inhibition of Cdk2 activity by olomoucine efficiently protects thymocytes from cell death induced by various stimuli (9).
Our results not only support a protective role for p21 WAF1/CIP1 in apoptosis but also indicate that cleavage of p21 WAF1/CIP1 associated with cyclin A-Cdk2 is a prerequisite event for apoptosis. This requirement for proteolytic cleavage of p21 WAF1/CIP1 in G-Rh2-induced apoptosis may be through the resulting up-regulation of cyclin A-Cdk2 kinase activity. The following observations support this hypothesis. First, the suppression of apoptosis by overexpression of either wild type p21 WAF1/CIP1 or p21D112N is well correlated with the downregulation of cyclin A-Cdk2 activity in transfected HeLa cells treated with G-Rh2. This inhibitory effect on cyclin A-Cdk2 kinase activity is more pronounced in the p21D112N transfectants (Fig. 4E) . Second, the amounts of p21 WAF1/CIP1 associ- FIG. 7 . Activation of cyclin-associated kinases in apoptotic HUVEC induced by G-Rh2 treatment or growth factor deprivation. HUVEC were induced apoptosis by treatment with 12 M G-Rh2. Cell lysates were prepared at every 30 min for 2 h after G-Rh2 treatment. Most of cells revealed apoptotic morphology at 2 h after G-Rh2 treatment. HUVEC were separately induced apoptosis by incubating the cells in RPMI 1640 medium without growth factors and prepared at the indicated times. Apoptosis of HUVEC was assessed by the proteolytic cleavage of PARP, and morphological changes were assessed by microscopy (data not shown). The cyclin A-and cyclin E-associated kinase activities and protein levels of PARP, p27
KIP1
, and p21
WAF1/CIP1 in cell lysates were determined as described in the legends to Figs. 1 and 2 , respectively. ated with the kinase complex decreased more slowly in p21D112N transfectants than they did in wild type p21 WAF1/CIP1 transfectants after treatment with G-Rh2 (Fig.  4F) . By contrast, the amount of p21 WAF1/CIP1 associated with cyclin A-Cdk2 is much lower in the mock transfectants after treatment with G-Rh2 (Fig. 4F) . Thus, in wild type p21 WAF1/CIP1 and p21D112N transfectants, the amount of p21 WAF1/CIP1 associated with cyclin A-Cdk2 correlates with both a suppressive effect on apoptosis and down-regulation of kinase activity in a time-and dose-dependent manner (Fig. 4,  C-F) . Therefore, it is reasonable to suggest that proteolytic cleavage of p21 WAF1/CIP1 that is associated with cyclin A-Cdk2 is a major mechanism for up-regulation cyclin A-Cdk2 kinase activity in the early stages of apoptosis.
Additional experimental observations suggest that this consequent up-regulation of cyclin A-Cdk2 kinase activity is required for apoptosis in both SK-HEP-1 and HeLa cells induced by treatment with G-Rh2. First, in HeLa cells transfected with cyclin A, Cdk2-dn, or cyclin A and Cdk2-dn. (Fig. 6) , we found that G-Rh2-induced apoptosis is increased dramatically by overexpression of cyclin A. However, this increase in apoptosis is blocked by co-transfection with Cdk2-dn (Fig. 6C) . Similarly, cyclin A-Cdk2 kinase activity is greatly up-regulated by overexpression of cyclin A, and this up-regulation is also blocked by co-transfection with Cdk2-dn (Fig. 6, B and D) . Second, we showed that olomoucine, a specific Cdk inhibitor, is able to block G-Rh2-induced cell death in a dose-dependent manner (Fig. 5B) . Furthermore, the changes in morphology and the nuclear fragmentation normally observed in apoptotic cells induced by treatment with G-Rh2 were blocked by addition of olomoucine to the culture media (Fig. 5A) .
Therefore, taken together, our results indicate that proteolytic cleavage of p21 WAF1/CIP1 and the consequent up-regulation of cyclin A-Cdk2 kinase activity may be linked ultimately to irreversible cell death.
